KU Leuven Rega Instituut

The MVVD (Molecular Vaccinology & Vaccine Discovery) team of Prof. Kai Dallmeier (at the Rega Institute, KU Leuven) focuses on the development of vaccines for neglected and emerging pathogens such as Zika virus (Kum et al. Nature PJ Vaccines 2018), Ebola (Lemmens et al., NPJ Vaccines, 2023) and SARS-CoV-2 (Sanchez-Felipe et al. Nature 2020; Sharma et al. Nature Comms. 2022), using the live-attenuated yellow fever YF17D vaccine as vector. Thermostable and easy to manufacture plasmid-launched versions thereof aim to tackle vaccine shortage and unmet public health needs faced by people living in LMIC.